Assembly Biosciences Revenue, Growth & Competitor Profile

DBA ASSEMBLY
DBA VENTRUS BIOSCIENCES LLC

Company Profile & Annual Report for Assembly Biosciences

Access the complete profile.

Assembly Biosciences Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	812 Personal & Laundry Services
Address	331 Oyster Point Blvd South San Francisco, CA 94080

Assembly Biosciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Assembly Biosciences's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Assembly Biosciences is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Assembly Biosciences is a publicly traded company on NCM using the ticker symbol ASMB. Detailed information on company financials and operating reports can be found here: NCM: ASMB

Assembly Biosciences Annual Revenue and Growth Rate

Assembly Biosciences	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Assembly Biosciences's revenues are gauged from an analysis of company filings.

Investor Activity

Assembly Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 24, 2010	8	93%	$1 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Assembly Biosciences is developing and marketing. Assembly Biosciences doesn't have any recent trademark applications, indicating Assembly Biosciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ASSEMBLY BIOSCIENCES Research and development in the bioscience and biotechnology fields	10/19/2015
GEMICEL Drug delivery systems	03/06/2015

See all trademarks and details in the Full Report.

Market Share of Assembly Biosciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Assembly Biosciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Assembly Biosciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GENENTECH	South San Francisco, CA	100
IGM BIOSCIENCES	Mountain View, CA	1
AKASA	South San Francisco, CA	1
MYOKARDIA	South San Francisco, CA	1
KRIYA THERAPEUTICS	Redwood City, CA	1
EPICRISPR BIOTECHNOLOGIES	South San Francisco, CA	1

Future Competition: Assembly Biosciences's Fastest Growing Competitors

These companies are in the same general field as Assembly Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)